Open Access · CC BY-NC-ND 4.0
ANTI-CD38 MONOCLONAL ANTIBODIES: TRANSFORMING MULTIPLE MYELOMA TREATMENT
Hematology, Transfusion and Cell Therapy · 2024-12 · 46 · S14-S15
DOI: 10.1016/j.htct.2024.11.108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematology, Transfusion and Cell Therapy, 2024-12. Verfasst von Cem Selim. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Selim, C. (2024). ANTI-CD38 MONOCLONAL ANTIBODIES: TRANSFORMING MULTIPLE MYELOMA TREATMENT. Hematology, Transfusion and Cell Therapy, 46, S14-S15. https://doi.org/10.1016/j.htct.2024.11.108
Vancouver
Selim C. ANTI-CD38 MONOCLONAL ANTIBODIES: TRANSFORMING MULTIPLE MYELOMA TREATMENT. Hematology, Transfusion and Cell Therapy. 2024;46:S14-S15. doi:10.1016/j.htct.2024.11.108
BibTeX
@article{Selim2024,
author = {Selim, Cem},
title = {ANTI-CD38 MONOCLONAL ANTIBODIES: TRANSFORMING MULTIPLE MYELOMA TREATMENT},
journal = {Hematology, Transfusion and Cell Therapy},
year = {2024},
volume = {46},
pages = {S14--S15},
doi = {10.1016/j.htct.2024.11.108}
}
EUVIMED